lead has been researched along with Endomyocardial Fibrosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Becker, H; Bernhardt, R; Bureik, M; Dragan, CA; Hübel, K; Lenz, N; Scher, J | 1 |
1 other study(ies) available for lead and Endomyocardial Fibrosis
Article | Year |
---|---|
Development of test systems for the discovery of selective human aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) inhibitors. Discovery of a new lead compound for the therapy of congestive heart failure, myocardial fibrosis and hypertension
Topics: Cushing Syndrome; Cytochrome P-450 CYP11B2; Drug Evaluation, Preclinical; Endomyocardial Fibrosis; Enzyme Inhibitors; Heart Failure; Humans; Hypertension; Lead; Recombinant Proteins; Schizosaccharomyces; Steroid 11-beta-Hydroxylase; Substrate Specificity | 2004 |